Company Profiles

driven by the PitchBook Platform

NanoBio

Description

Provider of vaccines designed to prevent respiratory diseases and offer mucosal immunity. The company's vaccines with adjuvant technology elicit both systemic and mucosal immune responses, enable its clients to protect themselves from world's most severe respiratory and sexually transmitted diseases that enter inside the body through mucosal surfaces.

2000

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$775k

Latest Deal Amount

$71.5M

Total Amount Raised

Description

Provider of vaccines designed to prevent respiratory diseases and offer mucosal immunity. The company's vaccines with adjuvant technology elicit both systemic and mucosal immune responses, enable its clients to protect themselves from world's most severe respiratory and sexually transmitted diseases that enter inside the body through mucosal surfaces.

Website:

www.nanobio.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals

Primary Office

2311 Green Road Ann Arbor, MI 48105United States +1 (734) 302-4000
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore NanoBio's full profile, request a free trial.

    NanoBio Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    NanoBio Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    NanoBio Investors (11)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Centre Lane PartnersPE/BuyoutMinority000 0000000 0000
    Lawrence BlackAngel (individual)Minority000 0000000 0000
    Line Moon VenturesOtherMinority000 0000000 0000
    Michigan Investment in New Technology StartupsVenture CapitalMinority000 0000000 0000
    National Institute Of Allergy and Infectious DiseasesGovernment000 0000000 0000
    Centre Lane Partners PE/Buyout
    Lawrence Black Angel (individual)
    Line Moon Ventures Other
    Michigan Investment in New Technology Startups Venture Capital
    National Institute Of Allergy and Infectious Diseases Government

    NanoBio Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    David PeraltaChief Executive Officer & Board Member
    Susan Ciotti Ph.DDirector, Formulations
    Douglas SmithDirector, Immunology
    Stephen GraconRegulatory Consultant
    Vira Bitko Ph.DSenior Director of Vaccine Research
    David Peralta Chief Executive Officer & Board Member
    Susan Ciotti Ph.D Director, Formulations
    Douglas Smith Director, Immunology
    Stephen Gracon Regulatory Consultant
    Vira Bitko Ph.D Senior Director of Vaccine Research

    NanoBio Board Members (9)

    NameRepresentingRoleSinceContact
    Info
    Chad CostleySelfBoard Member000 0000
    David PeraltaNanoBioChief Executive Officer & Board Member000 0000
    David StoutSelfBoard Member000 0000
    Gary Costley Ph.DSelfBoard Member000 0000
    George AridaVenture InvestorsAdvisor000 0000
    Chad Costley Board Member Self
    David Peralta Chief Executive Officer & Board Member NanoBio
    David Stout Board Member Self
    Gary Costley Ph.D Board Member Self
    George Arida Advisor Venture Investors
    Request full access to PitchBook